Cardiol Therapeutics Raises $13.5M through Bought-Deal Private Placement

viernes, 16 de enero de 2026, 9:09 am ET1 min de lectura
CRDL--

Cardiol Therapeutics has raised $13.5M through a bought-deal private placement with Canaccord Genuity. The company will issue 10.38M units priced at $1.30 each. The underwriter has an option to purchase up to an additional 10% of units, potentially increasing proceeds. The funds will be used for general corporate purposes.

Cardiol Therapeutics Raises $13.5M through Bought-Deal Private Placement

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios